Molecular genotyping in medullary thyroid cancer

被引：0
|
作者：
Newbold, Kate [1 ,2 ]
机构：
[1] Royal Marsden NHS Fdn Trust Hosp, London, England
[2] Royal Marsden NHS Fdn Trust Hosp, Consultant Clin Oncologist, Fulham Rd, London SW3 6JJ, England
来源：
CURRENT OPINION IN ONCOLOGY | 2023年 / 35卷 / 01期
关键词：
medullary thyroid cancer; rearranged during transfection; ACQUIRED-RESISTANCE; RET PROTOONCOGENE; RAS MUTATIONS; CARCINOMA; ACTIVATION; SELPERCATINIB; CABOZANTINIB;
D O I：
10.1097/CCO.0000000000000915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of reviewThere has been a significant advance in our understanding of the molecular biology of medullary thyroid cancer (MTC) alongside progress in the development of targeted therapies including multikinase and specific rearranged during transfection inhibitors.Recent findingsThis review will examine the latest data investigating the impact of the genomics of MTC on the prediction of the natural history of an individual's disease and the determination, selection and timing of treatment interventions.Recent advances in genotyping in MTC and the development of targeted therapies have impacted on the clinical management of both sporadic and hereditary MTC.
引用
收藏
页码：10 / 14
页数：5
相关论文
共 50 条
  • [1] Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence
    Sheikh, HA
    Tometsko, M
    Niehouse, L
    Aldeeb, D
    Swalsky, P
    Finkelstein, S
    Barnes, EL
    Hunt, JL
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (01) : 101 - 106
  • [2] Molecular advances in medullary thyroid cancer diagnostics
    Hubner, Richard A.
    Houlston, Richard S.
    [J]. CLINICA CHIMICA ACTA, 2006, 370 (1-2) : 2 - 8
  • [3] Progress in Molecular Targeted Therapy for Thyroid Cancer: Vandetanib in Medullary Thyroid Cancer
    Solomon, Benjamin
    Rischin, Danny
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (02) : 119 - 121
  • [4] Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies
    Cakir, Mehtap
    Grossman, Ashley B.
    [J]. NEUROENDOCRINOLOGY, 2009, 90 (04) : 323 - 348
  • [5] Medullary Thyroid Cancer: New Targeted Molecular Therapies
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Minuto, Michele
    Corrado, Alda
    Bruno, Rossella
    Miccoli, Paolo
    [J]. RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2010, 4 (01) : 10 - 14
  • [6] Medullary thyroid cancer: therapeutic targets and molecular markers
    Ball, Douglas W.
    [J]. CURRENT OPINION IN ONCOLOGY, 2007, 19 (01) : 18 - 23
  • [7] Medullary thyroid cancer: molecular factors, management and treatment
    Pavlidis, Efstathios
    Sapalidis, Konstantinos
    Chatzinikolaou, Fotios
    Kesisoglou, Isaak
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2020, 61 (03): : 681 - 686
  • [8] Medullary thyroid cancer
    Kissin, A
    Batheja, N
    [J]. THYROID, 2000, 10 (03) : 281 - 281
  • [9] Medullary thyroid cancer
    Clayman, GL
    El-Baradie, TS
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2003, 36 (01) : 91 - +
  • [10] MEDULLARY CANCER OF THE THYROID
    GOSSOT, D
    DUBOST, C
    SARFATI, E
    [J]. GAZETTE MEDICALE, 1987, 94 (12): : 59 - &
12345